These analyses showed that increased KDM7A-DT expression levels correlate with advanced BRCA histologic grade and system-level aberrations, including aneuploidy, CNA, HR defects, tumor burden, lymphocyte count, intel neoantigens, and several other well-established cancer markers and scores of BRCA progression and heterogeneity. This evidence concerns the gene KDM7A and cancer.